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Available online 01 November 2016An immobilization system constituted by coatedmicrocapsules was developed aiming at immobilizing probiotic
bacteria capable of producing folate and release it in a sustained manner into the intestine. Despite no probiotic
folate-producers have been immobilized so far, the system has been developed with this goal and this work re-
ports its stability and ability to release folate under gastro-intestinal conditions.
Microcapsules were made of alginate with three consecutive coatings of poly-L-lysine, sodium alginate and chi-
tosan. Turbidity experiments showed a strong electrostatic interaction between these polymers. Fourier trans-
form infrared spectroscopy (FTIR) and confocal analysis showed the stability of the coating materials when
applied on the microcapsules, even after they were immersed in solutions simulating conditions in the stomach
and small intestine (i.e. pH 2, 60 min and pH 7.2, 120 min, respectively). Coated microcapsules have an average
diameter size ranged from20 and 40 μm, and swelled upon exposure to a neutralmedium,without dissolution as
showed by microscopy analyses. Release experiments proved the ability of the coated microcapsules to release
folic acid, at different rates, depending on the applied coating. Release experiments showed that the ﬁrst coating
(Ɛ-PLL) is characterized by Fickian diffusion as themain releasemechanismof folic acid. Fickian rate constant (kF)
decreased with the number of consequent coatings, reﬂecting the decrease of predominance of Fick's behavior.
Results showed that the developed coated microcapsules have suitable characteristics for encapsulation of folic
acid aiming in situ release in the intestine.
© 2016 Elsevier Ltd. All rights reserved.Keywords:
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Folate is a vitamin that occurs in a large number of forms, being all
derived from folic acid (pteroylglutamic acid). However there are
different forms of folate, being the most known folic acid and 5-
methyltetrahydrofolic acid (Belz &Nau, 1998). Folate is part of some im-
portant metabolic pathways, such as methyl group biogenesis and syn-
thesis of nucleotides, vitamins and amino acids (Jacob, 2000). According
to the World Health Organization, folate deﬁciency is often associated
withmegaloblastic anemia, risk of lowbirthweight and placental abrup-
tion, risk of delivering preterm or small-for-gestational-age infants, risk
of neural tube defects (NTD), depression or even dementia (de Benoist,
2008). The increased cancer risk is also reported in other studies
(Stolzenberg-solomon et al., 2006). Folate fortiﬁcation in food to main-
tain recommended daily intake (350 μg for adults and 600 μg for.pregnantwomen)has been used using the synthetic formof B9 vitamin,
folic acid (European Food Safety Authority, 2014). However, folic acid
has low bioavailability after food processing, storage and consumption,
due to inefﬁcient absorption (deMeer et al., 2005). More than that, folic
acid has the capacity tomask, in an initial phase, vitamin B12 deﬁciency
(Bailey & Ayling, 2009; Morris & Tangney, 2007), while also changing
the activity of the hepatic dihydrofolate reductase enzyme (Bailey &
Ayling, 2009) and promoting cancer (Baggott, Oster, & Tamura, 2012;
Ulrich & Potter, 2006). Considering all these reasons, food fortiﬁcation
by a natural folate form is highly recommended.
Some probiotic bacteria, such as Lactococcus lactis cremoris, Strepto-
coccus thermophilus, Biﬁdobacterium lactis, B. breve, B. infantis and B.
animalis are capable of producing large amounts of folate (Crittenden,
Martinez, & Playne, 2003; Sybesma, Starrenburg, Tijsseling, Hoefnagel,
& Hugenholtz, 2003). However, several factors limit probiotics' action
in the human body, such as very weak resistance to gastro-intestinal
conditions (Gueimonde & Salminen, 2006) and low residence time in
the intestine (Gardiner et al., 2004; Klingberg & Budde, 2006). A
122 P.E. Ramos et al. / Food Research International 90 (2016) 121–132possible solution to these problems mentioned above could be the en-
capsulation of folate-producers probiotics. Microcapsules are able to
protect probiotics against high oxygen levels (Sunohara et al. 1995),
food products (Tripathi & Giri, 2014), freezing (Azizi et al., 2010;
Sousa et al., 2013), and during the passage through the gastrointestinal
tract (Sun&Grifﬁths, 2000). Other limitation could be the direct contact
of these bacteria with human gut, following reports mentioning con-
cerns about the probiotics utilization in humans, such as: possible pas-
sage from the digestive tract to extra-intestinal sites, leading to
infections (Butel, 2014), and an excessive immune stimulation by a di-
rect contact of probioticswith the gut, that creates continuous immuno-
logical responses by human organism (Marteau & Shanahan, 2003).
However, a full and continuous encapsulation during the passage
through the gastrointestinal system can provide other advantages
such as the prevention of the interfacial activation, stimulation of pro-
duction and excretion of secondary metabolites (Nazzaro et al., 2012).
Alginate is the most applied material in microcapsules formation
due to its low price, ease of gelation and biocompatibility (Chen, Cao,
Ferguson, Shu, & Garg, 2012; Klein, Stock, & Vorlop, 1983; Quong,
Neufeld, Skjåk-Braek, & Poncelet, 1998; Smidsrd & Skjak-Brae, 1990;
Tanaka & Matsumura, 1983). Alginate is a polysaccharide extracted
from brown algae and is composed of randomly 1–4 linked β-D-
mannuronic acid andα-L-guluronic acid,M blocks andG blocks, respec-
tively (Smidsrd & Skjak-Brae, 1990). The ratio between these two blocks
(M/G ratio) leads to alginates with different characteristics when
crosslinkedwith calcium, as only G blocks bind to calcium. This has a di-
rect inﬂuence on the encapsulation efﬁciency, swelling and release ki-
netics. In microcapsule formation, alginates with a high M/G ratio will
be more permeable and will have a faster release of encapsulated com-
pounds (Khanna,Moya, Opara, & Brey, 2010). Alginateswith a lowerM/
G ratio will form stronger structures, which are less permeable and
more viscous due to the greater afﬁnity of the G blocks to calcium
ions, compared to M blocks (Sarmento et al., 2007). Divalent calcium
(Ca2+) is the most commonly used ion to create alginate-based micro-
capsules, although other ions can also be used (Tam et al., 2011). There
are different techniques for microencapsulation of probiotics, such as
extrusion, spray drying, emulsiﬁcation and coacervation (Rathore,
Desai, Liew, Chan, & Heng, 2013) but the production of microcapsules
smaller than 100 μm is less common in the literature. Microcapsules
smaller than 100 μm are important as they will not alter food texture
(Adhikari, Mustapha, & Grün, 2003) and thus their sensorial aspects.
Nevertheless, depending on their hardness there are even works that
refer microcapsules' sizes of 40 μm that change food texture (Engelen,
VanDer Bilt, Schipper, & Bosman, 2005). Sheu andMarshall (1993) pro-
duced sodium alginatemicrocapsules smaller than 100 μm, by emulsion
technique, as support to the alginate ionotropic gelation. Considering
the small diameters ofmicrocapsules below 100 μm, and that small cap-
sules (below 200 μm) are less efﬁcient for probiotics protection
(Heidebach, Först, & Kulozik, 2012), added barriers to protect microen-
capsulated probiotics have been developed, namely by using layer-by-
layer (LbL) assembly. Electrostatic LbL coating involves the assembly
of materials of opposite charge e.g. through exposure to alternating so-
lutions of cationic and anionic polymers (Cook, Tzortzis, Khutoryanskiy,
& Charalampopoulos, 2013; Krasaekoopt, Bhandari, & Deeth, 2006).
Different polysaccharides and proteins have been used to form LbL
coatings (Tang, Wang, Podsiadlo, & Kotov, 2006; Yan, Björnmalm,
& Caruso, 2014). Alginate |poly-L-lysine|alginate is a well-known
combination of coatingswhich have been used on alginate basedmicro-
capsules. The interactions between these two polymers (alginate and
poly-L-lysine (PLL)), in most cases leading to a LbL assembly, are
based in the electrostatic interactions between the anionic groups
COO− present in alginate and the cationic groups NH3+ present in PLL
(Orive, Tam, Pedraz, & Hallé, 2006). The electrostatic interactions of
PLL are enhanced when the amount of M blocks present in alginate is
higher, in others words, PLL cationic groups have more afﬁnity for M
blocks compared to the G blocks (Thu, Bruheim, Espevik, & Skj, 1996).Chitosan has been one of the most used materials to improve the pro-
tection of probiotics, e.g. as a coating on alginate microcapsules
(Chávarri et al., 2010; Kamalian, Mirhosseini, Mustafa, & Manap,
2014). Chitosan and alginate have also demonstrated mucoadhesive
properties that are important to be used to increase the residence
time of microcapsules in the gut (Sarmento et al., 2007; Takeuchi et
al., 2005).
The objective of this work was developing an alginate-based
probiotics encapsulation system smaller than 100 μm, with a ratio-
nally designed coating developed through LbL assembly. It has
being developed aiming to host probiotic bacteria while being able
to pass through the gastrointestinal system up to the point at
which adhesion to the intestinal mucosa can be achieved, with the
consequent exchange of nutrients and products (probiotic activation
and a continuous encapsulation) in the intestine. This approach will
increase the residence time of probiotics in the intestine and will
avoid possible inﬂammatory responses or infections provoked by di-
rect contact of probiotic bacteria with the intestinal mucosa. In this
work will only be presented the development and characterization
of the system and the results considering probiotics encapsulation
and protection, as adhesion will not be explored. The developed sys-
tem will be characterized in terms of size, swelling capacity, folate
release behavior and the chemical interactions between the capsule
and the coatings (FTIR analysis).
2. Materials and methods
2.1. Materials
Sodiumalginates “Protanal CR 8223” (M/G ratio 65/35; 250–350 kDa)
and “Protanal LFR5/60” (M/G ratio 30/70; 20–60 kDa) were purchased
from FMC Biopolymer (Belgium). Ɛ-poly-L-lysine (Ɛ-PLL) was purchased
from Handary (Belgium – molecular weight - 30 kDa). Chitosan was
obtained from Golden-Shell Biochemical Co. Ltd. (China - molecular
weight - 5–10 kDa) with a degree of deacetylation of 95%. Corn oil,
Tween 80 (Panreac, Germany), ﬂuorescein isothiocynate (FITC), rhoda-
mine B isothiocynate (RITC), 1-ethyl-3-(-3-dimethylaminopropyl)
carbodiimide hydrochloride (EDC), N,N-dimethylformamide and folic
acid were purchased from Sigma (USA).
2.2. Turbidity measurements
All polymer solutions (0.1% w/v) were prepared in deionized water,
except chitosan whichwas dissolved in a 1% (v/v) lactic acid solution. A
mixture of 5mLof each solutionwas used, testing some combinations of
biopolymers to be used as coating materials (sodium alginate CR 8223
with Ɛ-PLL; Ɛ-PLL with sodium alginate LFR5/60; sodium alginate
LFR5/60 with chitosan). The pH of each mixture was adjusted with
0.2 mol·L−1 hydrogen chloride or 0.2 mol·L−1 sodium hydroxide solu-
tions, in the range of 2 to 8. In order to standardize the compounds con-
centration in all samples after pH adjustment, sodium chloride
(0.2 mol·L−1) was added to obtain the same ﬁnal volume in all experi-
ments. Turbidity measurements were performed on a spectrophotome-
ter at 400 nm (Jasco V560, Jasco Corporation, Japan).
2.3. Microcapsules production
Microcapsuleswere produced according to themethod described by
Sheu and Marshall (1993). These ﬁrst tests were performed without
bacteria to facilitate coated microcapsules characterization. The micro-
capsuleswere produced by dropwise addition of 20mL sodium alginate
(CR 8220), with a concentration of 1.5%, into a 100 mL solution of veg-
etable oil with a concentration of 0.2% of Tween 80. The mixture was
then stirred for 10min at 200 rpm. After this, a solution of 200mLof cal-
cium chloride (0.05 M) was gently added during 20 s and the mixture
stirred at 200 rpm for 20 min. After hardening, the solution was passed
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uid (oil andwater)was gently removedwith a pipette. The residual vol-
ume containing the microcapsules was then ﬁltered through a 100 μm
nylon ﬁlter using water to remove the residual oil. After ﬁltration the
microcapsules that passed through the ﬁlter (smaller than 100 μm)
were centrifuged for 5 min at 600 rpm (Centrifuge Heraeus Megafuge
1.0R) and isolated.
2.4. Layer-by-layer assembly - coated microcapsules production
After production, themicrocapsuleswere immersed in a 0.01% Ɛ-PLL
solution (10 mL), with constant stirring of 200 rpm for 15min, forming
the coatedmicrocapsuleswith a single coat. Then, the solutionwas cen-
trifuged in themannermentioned before. The next stepwas the immer-
sion of the coated microcapsules (alginate|Ɛ-PLL) into a sodium
alginate (LFR5/60) solution (0.1%, 10mL) for 15min, followed by centri-
fugation (600 rpm, 10 min). The recovered coated microcapsules (dou-
ble coated)were then immersed into a chitosan solution (0.01%, 10mL).
After that, another centrifugation step separated the coated microcap-
sules from the chitosan solution.
2.5. Fourier transform infrared (FTIR) spectroscopy
In order to conﬁrm the adhesion of the different coatings, FTIR anal-
yses were carried out with a Perkin Elmer 16 PC spectrometer (Perkin
Elmer, Boston, MA, USA) in the wavenumber region of 600–
4000 cm−1 using 16 scans for each sample. Themicrocapsules and coat-
ed microcapsules were freeze-dried prior to FTIR measurements.
2.6. Diameter measurement
Diameter measurements were performed through microscopy with
a 10× magniﬁcation (Olympus BX51). Images of the samples were
taken and at least 200 capsules were measured with Image J software.
2.7. Testing of microcapsules and coated microcapsules in different pH's
Microcapsules and coated microcapsules were immersed into a
10 mL solution of potassium chloride - hydrogen chloride (pH 2) for
1 h, stirred at 100 rpm. Then, the solution was centrifuged and the mi-
crocapsules and coatedmicrocapsules were put into a phosphate buffer
saline (PBS) solution (pH 7.2), for 3 h. Aliquots of 100 μL were taken
every 15 min. During the PBS solution test, that has a duration of 3 h,
samples were taken every 45 min. Each experiment was performed in
triplicate. These experiments were performed in microcapsules and
coated microcapsules with one coating (Ɛ-PLL), two coatings (previous
coating and alginate) and with three coatings (previous coatings and
chitosan). All these experiments were performed independently and
in triplicate. For each sample, diameter measurements were performed.
2.8. Compounds labeling
Chitosan-[RITC] was prepared bymixing 100mL of 1% chitosanwith
50 mg RITC and 20 mg EDC at 4 °C for 1 day. Alginate-[FITC] was
prepared by mixing 100 mL of 1.76% alginate with 10 mg FITC and
20 mg EDC at 4 °C for 1 day. The residual free dye was then dialyzed
off (molecular weight cut-off 3500 Da; Cell-Sep. H1, Membrane Filtra-
tion products, USA) with double distilled water for 2 weeks (Chang,
Lee, Wu, Yang, & Chien, 2012). To the FITC-labeled Ɛ-PLL, 0.1% of a Ɛ-
PLL solution was dissolved in 0.2 M NaHCO3 buffer (pH 9) and 1.0 mg
(0.0026 mmol) of FITC was dissolved in N,N-dimethylformamide. Both
solutions were stirred overnight. The Ɛ-PLL/FITC solution was puriﬁed
by dialysis (molecular weight cut-off 1000 Da; Cell-Sep. H1, Membrane
Filtration products, USA) and the compoundwas dried by freeze-drying
for further utilization (Kleinberger, Burke, Dalnoki-Veress, & Stöver,
2013).2.9. Confocal microscopy analyses during the gastrointestinal pH
simulation
The same media and conditions were used as mentioned in Section
2.7 but samples were taken at 5 min and 60 min in the potassium chlo-
ride - hydrogen chloridemedium and at 5min and 3 h in the PBSmedi-
um. All samples were analyzed by confocal microscopy (Nikon A1-R
Confocal with Resonant Scanner). Independent experiments were per-
formed where just the studied coating was labeled.
2.10. Kinetic release proﬁles
The release kinetics of folic acidwas studied using an in vitro dialysis
method. Folic acid was added to sodium alginate solution used for mi-
crocapsules' production, forming a solution with a concentration of
folic acid of 2%. The process of coated microcapsules' production was
the same as mentioned before. Each production batch (10 mL volume)
was divided in two different experiments. Each experiment had 5 mL
of coated microcapsules that were introduced in a dialysis membrane
(molecular weight cut-off 15 kDa, Cellu-Sep. H1, Membrane ﬁltration
products, USA), which was subsequently placed into 40 mL of PBS solu-
tion, under magnetic stirring, at 37 °C, with no exposure to light. At ap-
propriate time intervals, 0.8 mL of supernatant were taken and fresh
medium was replaced to keep the initial volume constant. The amount
of folic acid released from the coated microcapsules was evaluated by
measuring the absorbance at 309 nm (Elisa Biotech Synergy HT, Biotek,
USA). Coated microcapsules were produced without folic acid and a re-
lease experimentwas performed proving that no signiﬁcant absorbance
could be measured from the samples of that experiment.
All the tests were run at least in triplicate.
2.11. Mathematical modeling
Folic acid release proﬁle from the coatedmicrocapsuleswas evaluat-
ed using a kineticmodel that accounts for both Fickian and Case II trans-
port (linear superposition model - LSM) effects in hydrophilic matrices
(Berens & Hopfenberg, 1978b):
Mt: ¼ MF þMR ð1Þ
where Mt. is the total mass released from the coated microcapsule,MF
andMR are the contributions of the Fickian and relaxation processes, re-
spectively, at time t.
The Fickian process is described by:
Mt; F ¼ M∞; F 1− 6
π2
∑
∞
n¼1
1
n2
exp −n2kFt
   ð2Þ
where
K F ¼ 4π
2D
d2
ð3Þ
M∞,F is the compound release at equilibrium, D is diffusion coefﬁ-
cient and d is the capsule diameter.
As for polymer relaxation, it is driven by the swelling ability of the
polymer and it is therefore related to the dissipation of stress induced
by the entry of the penetrant and can be described as a distribution of
relaxation times, each assuming a ﬁrst order-type kinetic equation
(Berens & Hopfenberg, 1978a).
Mt;R ¼∑
i
M∞; i 1− exp −Ki; tð Þ½  ð4Þ
where each Ki is the respective relaxation rate constant and each M∞,i
represents the equilibrium sorption of the ith relaxation process.
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(1)) results in:
Mt; F ¼ M∞; F 1− 6
π2
∑
∞
n¼1
1
n2
exp −n2kFt
  
þ∑
i
M∞;Ri 1− exp −KRi; tð Þ½  ð5Þ
This “general” model can then be used to describe pure Fickian
(Mt,F ≠ 0 and i = 0); anomalous (Mt,F and i ≠ 0) or Case II (Mt,F = 0
and i ≠ 0) transports.
2.12. Statistical analyses
Statistical analyses were performed using the analyses of variance
(ANOVA) procedure with SigmaPlot 11.0 software for windows,
where a p b 0.05was considered to be statistically signiﬁcant, on the di-
ameter and turbidity measurements.
Eq. (5) was ﬁtted to data by non-linear regression, using STATISTICA
v7.0 (Statsoft. Inc., USA). The Levenberg-Marquardt algorithm for the
least squares function minimization was applied. Adjusted determina-
tion coefﬁcient (R2), squared root mean square error (RMSE) (i.e., the
square root of the sum of the squared residues (SSE) divided by the re-
gression degrees of freedom) and residuals inspection for randomness
and normality were evaluated to determine regressions quality. Stan-
dardized Halved Width (SHW %) (i.e. the ratio between 95% Standard
Error and the value of the estimate) was assessed to determine preci-
sion of the estimated parameters.
3. Results and discussion
The design of this system was made with the following criteria: the
utilization of alginate CR 8223, that has a 65/35 ratio of the M/G blocks
and a high molecular weight (app. 300 kDa) was meant to form a main
core with high permeability due to its high molecular weight and high
content of mannuronic residues (responsible for swelling and less afﬁn-
ity by calcium ions). The use of PLL, as the ﬁrst coating, is expected to
limit the continuous swelling of the alginate microcapsule that leads
to erosion in the media containing monovalent ions and calcium
sequestrants, while maintaining the permeability of the coated micro-
capsule. The subsequent coating, alginate LFR5/60, has a 30/60 M/G
ratio and a low molecular weight. PLL has more afﬁnity for M blocks
than G blocks, which will promote electrostatic interactions between
the ﬁrst and the second coating (Thu et al., 1996). This second alginate
coating will also work as a way to guarantee the interaction between
PLL and chitosan (to be used in the third and last coating), maintaining
the permeability of the system, and working as a bioadhesive material
in the case of chitosan erosion. Chitosan used as the last coating has
two main objectives: to protect the system (mainly the probiotics) in
acidic environments and be responsible for the adhesion of coated mi-
crocapsules to the intestinal epithelium. The presented system, with
the utilization of these speciﬁc materials and with that speciﬁc order,
was never used before for the development of a coated microcapsule
system. The combination of thesematerials creates a new coatedmicro-
capsule system that might have new functions and applications, such as
the controlled release of micronutrients. Some of these characteristics
will be studied and demonstrated in this work, others will be explored
in a future work.
3.1. Turbidity measurements
Turbidity tests were performed to demonstrate that the coatingma-
terials effectively interact with each other via their charged groups,
which are responsible by the electrostatic interactions established be-
tween them. Thematerials used to build the different coatings on the al-
ginate microcapsules were: a) alginate CR 8223, negatively chargedmaterial at pH values above its pKa; b) Ɛ-PLL, positively charged mate-
rial at pH values below its isoelectric point (pI); c) alginate LFR5/60,
negatively charged material at pH values above its pKa (An et al.,
2013; Cook, Tzortzis, Charalampopoulos, & Khutoryanskiy, 2012); d)
chitosan, positively charged material at pH values above its pKa.
The turbidity of these four different solutions was measured at pH
values between 2 and 8, ensuring that the OD was never above
0.08 a.u. This conﬁrms that any turbidity above this is the result of poly-
electrolyte complex formation. The ﬁrst experiment was performed
with alginate CR 8223 and Ɛ-PLL. The results showed a better interac-
tion between the biopolymers at pH 5–6 (Fig. 1), as shown by higher
OD values, being those statistically different for all experiments but
not different at pH 4 (p b 0.05). The rest of the experiments are all sta-
tistically similar, but their minimal values of OD (0.68 ± 0.05) are con-
siderably higher than the OD of the pure solutions, which indicates that
electrostatic interactions occurred between thesematerials in all the pH
range tested. These results can be justiﬁed considering that the pKa of
alginate is 3.3–3.7 (pKa values of mannuronic acid and guluronic acid
are 3.38 and 3.65, respectively (An et al., 2013)) and that the pI of Ɛ-
PLL is of approximately 9 (Yoshida & Nagasawa, 2003). The interactions
observable at pH 2 and 3 are possibly due to a remaining percentage of
functional groups charged in alginate at these pH values (pH at one
unity below the pKa of alginate, the molecule will still have 10% of the
functional groups charged (Po & Senozan, 2001)).
The same experiment was performed with Ɛ-PLL and alginate LFR5/
60 solutions (Fig. 1), which correspond to the ﬁrst and second coating of
the microcapsule, respectively. The results showed that the strongest
interactions between the two materials happen between pH 3 and 8,
where no statistically signiﬁcant differences are observed in that inter-
val (p b 0.05). As mentioned before, the lower OD obtained at pH 2
can be justiﬁed by a lower number of negatively charged functional
groups in alginate, at this pH. These results have a similar behavior
when compared with the interactions between alginate CR8223 and
Ɛ-PLL and similar electrostatic interactions are present in this experi-
ment. It is also important to mention that the observed OD values are
higher, in general, when comparing the interaction of alginate LFR5/60
and alginate CR 8223 with Ɛ-PLL. This fact can be justiﬁed by the stron-
gest afﬁnity of the amine groups of Ɛ-PLL with the glucuronic residues
(present in alginate) that are in a higher percentage in the alginate
LFR5/60 (Thu et al., 1996).
The turbidity measurements performed with alginate LFR5/60 and
chitosan showed that pH, as before, inﬂuenced the results (Fig. 1). The
pKa values of alginate and chitosan are 3.3–3.7 and 6.5 (Oliveira et al.,
2014), respectively, which indicates that strong interactions are to be
expected between the biopolymers at pH values between 3 and 5,
being those statistically different of the rest (p b 0.05) (as mentioned
above, at pH values near the pKa, half of the molecule's functional
groups are charged). The results obtained between pH 6 and 8 cannot
be differentiated from a statistical point of view, which considering
that those values are at the chitosan pKa or above that, means that chi-
tosan is reducing the number of its functional groups with positive
charge, and is starting to precipitate. In the tests at lower pH (pH 2)
the same is happening but with the alginate molecule. Electrostatic
forces are present in the interaction of chitosanwith alginate thus creat-
ing this signiﬁcant turbidity (Chávarri et al., 2010). The interaction of
thesematerials were also demonstrated in other workswhere a capsule
constituted by alginate and PLL was produced (Constantinidis et al.,
2007; Tam et al., 2005b). In other works were also proved the interac-
tion of alginate and chitosan on the production and coating of a micro-
capsule (Shi, Alves, & Mano, 2007; Zhao et al., 2007).
Turbidity results show that the materials used are able to interact,
being a good indication of the formation of a LbL structure on themicro-
capsule. This evaluation is also important to demonstrate that the devel-
oped system is stable for pH values between 2 and 7 (i.e. stomach and
intestine), which gives good perspectives to the utilization of this coated
microcapsule as a gastrointestinal delivery system. After turbidity tests
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Fig. 1. Turbidity measurements for alginate CR 8223, Ɛ-PLL, alginate LFR5/60 and chitosan. Different letters represent signiﬁcantly different values (p b 0.05).
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surements in order to add successfully the different coatings to the mi-
crocapsule. These tests were conducted as described in Carneiro-da-
Cunha et al. (2010) and the best solutions achieved were 0.01% for Ɛ-
PLL, 0.1% for alginate and 0.01% for chitosan.
3.2. Size measurement
Fig. 2 shows the diameter of the coated microcapsules through con-
secutive coating steps, demonstrating that coated microcapsules pro-
duced using this method are smaller than 100 μm, achieving that way
the ﬁrst goal of this work (microcapsules/coated microcapsules to pro-
tect bacteria that do not alter the texture/mouthfeel of the food product
they are to be dispersed in). During sequential coating steps, the coated
microcapsules' diameter decreased, comparing with microcapsules,
phenomena that can be explained by the different behavior of thesema-
terials at different pH values. The alginate used in the microcapsules
production has the capacity to swell through hydration that increased
the microcapsules volume; this happens after the production in the
ﬁnal washing step with water. This was also reported by Sriamornsak,
Thirawong, and Korkerd (2007) that tested a great number of alginates
types and proved that alginate-based matrices are susceptible to hy-
drate at a neutral pH. After generating themain core, the microcapsules
were added to a solution of Ɛ-PLL, creating the alginate|Ɛ-PLL coated
microcapsule (APM). This deposition decreased the diameter of the
coated microcapsules in comparison with the alginate microcapsules,
in a neutral pH, due to the ﬁrst coating formation. When APM were0
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Fig. 2.Microcapsule and coated microcapsules diameter through the coatings deposition
(capsules are immerged in water), A; and coated microcapsules' picture by microscope
with a 10× lent (scale bar 150 μm), B. Different letters represent signiﬁcantly different
values (p b 0.05).put into water the swelling was reduced by the Ɛ-PLL layer. This behav-
ior can be explained by the capacity of this coating to limit the high hy-
dration capacity, and consequent swelling capacity, of alginate
microcapsules (Lawrie et al., 2007). The consequent layers adhesion
creating the alginate|Ɛ-PLL|alginate coated microcapsule (APAM) and
alginate|Ɛ-PLL|alginate|chitosan (APACM) did not change the diame-
ter of the coated microcapsules, being the diameter results for the
three coated microcapsules statistically equal and all different from
the microcapsule diameter (p b 0.05).
3.3. FTIR results
FTIR results showed a signiﬁcant similarity between the microcap-
sules spectra main peaks and those of alginate CR 8223 (Fig. 3), in
both, the characteristic peaks of alginate at 3309 cm−1 (stretching vi-
brations of hydrogen-bonded OH groups), 1590 cm−1 and 1400 cm−1
(stretching vibrations of the COO– - Fig. 3(B)) are present (Shi et al.,
2007; Shi, Alves, &Mano, 2007; Tam et al., 2005a, 2005b). Just onmicro-
capsules spectrum, two consequent peaks can be found at 2922 and
2852 cm−1 (Fig. 3(A)) and another one at 1743 cm−1 (Fig. 3(C)), both
being the consequence of the presence of oil (Meng, Pan, Ding, &
Jiang, 2014; Vlachos et al., 2006).
Considering the spectra presented in Fig. 4, it is possible to identify
that the oil spectra keep being present in all samples. The consequent
coating adhesion showed that there are no signiﬁcantmodiﬁcations be-
tween the alginate microcapsules spectra and the coated microcapsules
spectra. On the alginate microcapsules and APM spectra there are rele-
vant differences such as the formation of two shoulders on both sides of
peak 1590 (Fig. 4(A)), that correspond to the strong Amide I
(~1637 cm−1) and Amide II (~1552 cm−1) OD bands of the Ɛ-PLL
(Tam et al., 2005a, 2005b). The presence of those peaks proves the pres-
ence of Ɛ-PLL in the APM structure. The presence of alginate LFR5/60 is
difﬁcult to prove considering that its spectra is the same as the one of
the initial alginate microcapsule, although it is possible to notice that
the two shoulders presented in the last spectrum (APM spectra) charac-
teristic of Ɛ-PLL, disappear in the APAM spectrumwhich proves that the
alginate coating was well succeed. Some characteristic peaks can be
seen in Fig. 4(B) in the APACM spectrum, that are characteristic of the
presence of chitosan, such as the one found at 1567 cm−1; this is a typ-
ical peak of the interaction between the negatively charged group COO–
of alginate and the positively charged groups NH3+ of chitosan. This peak
is also responsible for the obstruction of the 1590 cm−1 alginate peak.
This behavior can be found in other works dealing with the coating of
alginate with chitosan (Shi et al., 2007). The 1729 cm−1 peak (Fig.
4(C)) can be justiﬁed by the protonation of alginate, due to the contact
Fig. 3. FTIR spectra of alginate powder and alginate microcapsules. A – Representation of 2852 and 2922 cm−1 peaks; B – representation of 1590 and 1400 cm−1 peaks; C – representation
of the 1743 cm−1 peak.
126 P.E. Ramos et al. / Food Research International 90 (2016) 121–132of chitosan (dissolved in lactic acid) with alginate (Lawrie et al., 2007).
These FTIR results show the successive adhesion of the different
coatings.3.4. Confocal microscopy analyses
The LbL assembly on alginate microcapsules was evaluated
through confocal microscopy in order to show the adhesion of the
materials to the main core microcapsule structure (Fig. 5). Alginate
CR 8223, Ɛ-PLL and alginate LFR5/60 were labeled with FITC and chi-
tosan was labeled with rhodamine. To test the presence of each coat-
ing only one coating was labeled in each experiment, in order to
differentiate all the coatings that were labeled with FITC. Confocal
microscopy images showed the existence of the alginate-based
microcapsules (Fig. 5a). Fig. 5b) shows the coated microcapsules la-
beled with Ɛ-PLL, coated due to the electrostatic forces between CO2–
groups, from alginate, and NH3+ from Ɛ-PLL (Bystrick, Malovl, &
Sticzay, 1990). Fig. 5c) shows the adhesion of the second coating,
composed of alginate LFR5/60. Fig. 5d) shows the presence of the
subsequent chitosan layer on that of alginate LFR5/60 coated micro-
capsule, being its adhesion justiﬁed by electrostatic forces between
the carboxyl groups of alginate and the amine groups of chitosan
(NH2+) (Gazori et al., 2009; Sarmento et al., 2007). With these confo-
cal images it was possible to prove the sequential adhesion of those
different coatings to the main microcapsule structure.Fig. 4. FTIR spectra of alginate microcapsule, APM, APAMand APACM. A - representation of ~163
of 1729 cm−1 peak.3.5. Evaluation of structures into two different media that simulate gastro-
intestinal pH
Testswere performed to determine the coatedmicrocapsules' diam-
eter in an acidic medium (potassium chloride - hydrogen chloride at
pH 2, 1 h), simulating stomach pH, and in a neutral pH medium (Phos-
phate Buffer Solution (PBS) – pH 7.2–3 h), simulating intestinal pH. Al-
ginate microcapsules showed a good resistance to the potassium
chloride - hydrogen chloride solution, as shown in Fig. 6. The structures
presented an average diameter of 33.81 ± 3.05 μm in that solution.
In PBS the microcapsules had a different behavior. After 5 min they
were starting to dissolve, making the measurement of their size impos-
sible. This is due to exchange between the sodium ions present in the
PBS solution and the calcium ions present in the alginate microcapsule,
togetherwith calcium sequestration by phosphates (Corona-Hernandez
et al., 2013). This process generates an increase of repulsion between
the COO– groups present in the alginate chains leading to a swelling of
the structure (water intake), at an initial stage, which will later lead to
a total collapse of the alginate microcapsule structure. Bajpai et al.
(Bajpai & Sharma, 2004) showed that alginate beads had the same be-
havior into a PBS solution, increasing their diameter during the ﬁrst
3 h and leading to a total dissolution of the materials after that. Similar
results were reported by Gao, Liu, Chen, and Zhang (2009).
To avoid the coated microcapsules' dissolution in the PBSmedium, a
coating was added on the alginate microcapsule. This coating will pre-
sumably lead to an increase of the structure's strength decreasing its7 cm−1 and ~1552 cm−1 peaks; B - representation of 1567 cm−1 peak; C - representation
Fig. 5. Representation of: a) alginate coated microcapsules (alginate labeled with FITC - scale 250 μm); b) APM (Ɛ-PLL labeled with FITC - scale 200 μm); c) APAM (alginate labeled with
FITC - scale 50 μm); d) APACM (Chitosan labeled with Rhodamine - scale 50 μm).
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the utilization of Ɛ-PLL as a coating on alginatemicrocapsules decreased
the swelling degree of the alginatemicrostructure in a monovalent ions
solution such as PBS (Capone et al., 2013; Tam et al., 2011). Fig. 7 shows
the diameter of the coatedmicrocapsules when immerged in potassium
chloride - hydrogen chloride and PBS solutions. It is clear that a) there is
no destruction of the coatedmicrocapsules in the PBS solution; b) coat-
ed microcapsules' diameter is stable during the contact with the differ-
ent media and there are no statistically signiﬁcant differences between
all diameters results in the potassium chloride - hydrogen chloride solu-
tion for all systems (p b 0.05) (average diameter of app. 20 μm) and theFig. 6.Microscopy images of the microcapsules after 1 h into the acidic medium (scale -
150 μm).same happens in the PBS solution, also for all systems (p b 0.05), being
the average diameter around 40 μm; and c) there is a swelling degree of
approximately 2-fold in diameter when coated microcapsules go from
the potassium chloride - hydrogen chloride solution to the PBS solution,
being that difference statistically signiﬁcant. The Ɛ-PLL coating showed
that it was able to protect the structure against the ion exchange pro-
cess, thus retarding its swelling.
Confocal microscopy was performed in order to evaluate the
eventual loss of layers during the contact with the potassium chloride
- hydrogen chloride and PBS media. As explained before, to test the
presence of each coating only one coating was labeled in each experi-
ment, in order to differentiate all the coatings that were labeled with
FITC. Fig. 8 shows that the three different coatings were still over each
other and attached to the main structure. Those results are in accor-
dance with other published works (Cui, Goh, Kim, Choi, & Lee, 2000;
Kamalian et al., 2014; Krasaekoopt et al., 2006; Tam et al., 2011).
3.6. Release kinetics of folic acid into phosphate buffer
Mathematical modeling of transport phenomena is important for
the design of carrier systems and of active compound carriers, since it
may help predicting behavior in vivo. In this work, we studied the de-
scription of experimentally obtained data by the Linear Superimposition
Model (LSM) (Eq. (5)). Themechanisms of folic acid release from coated
microcapsules were evaluated at 37 °C (temperature within the human
body) and at pH 7 (pH of the small intestine).
In order to evaluate the physical mechanisms involved in folic acid
release from coated microcapsules with different coatings it is impor-
tant to use a model that successfully describes the individual contribu-
tions of the diffusion and the relaxation processes. The LSM was ﬁtted
to the experimental data: concerning the Fickian part of the model
Fig. 7.Microcapsules and coated microcapsules diameter during immersion in potassium chloride - hydrogen chloride (0 to 60 min) and PBS (60 to 240 min) solutions in a consecutive
way, respectively. Different letters represent signiﬁcantly different values (p b 0.05).
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ported by other works, this model assumes that the transport mecha-
nism from coated microcapsules: i) can be due only to the
concentration gradient and polymer relaxation had no effect on the
transport mechanism (i.e. Fick's behavior; i = 0); or ii) transport can
be due to the sum of concentration gradient and to the relaxation of
the polymer matrix (i ≠ 1) (Pinheiro, Bourbon, Vicente, & Quintas,
2013).
Fig. 9 clearly shows the effect of applying different coatings on coat-
ed microcapsules in the folic acid release proﬁle. For each coating ap-
plied on the coated microcapsule, LSM ﬁtting curves showed a good
description of the experimental data. This indicates that this transport
mechanism cannot be described by Fick's diffusion of folic acid in the
coated microcapsules alone, but is governed by both Fickian and CaseFig. 8.Microcapsules and coated microcapsules after 3 h into the PBS medium (with a previou
microcapsule (alginate labeled with FITC - scale 100 μm); b) APM (Ɛ-PLL labeled with FITC -
labeled with rhodamine - scale 100 μm). Independent experiments were performed where onII transport. Also, it was observed that depending on the coating applied
in the coated microcapsules, this system was governed by two or more
relaxation processes.
Table 1 presents the regression analysis results of the LSM ﬁtting,
showing that this model adequately describes the experimental data
with relatively good regression quality (R2 N 0.90) and thatmost param-
eters were estimated with good precision.
The ﬁtting of LSMmodel to experimental data shows that themech-
anisms involved in folic acid release are composed by Fick diffusion con-
tribution (MF) and two or more relaxation processes (MR). The
application of the ﬁrst coating (Ɛ-PLL) on the coated microcapsule sug-
gests that Fick's diffusion is the main mechanism of folic acid release
from the coated microcapsule. These results can be explained based
on strong electrostatic interactions between alginate CR 8223 and Ɛ-s contact of 1 h into potassium chloride - hydrogen chloride medium): a) alginate-based
scale 25 μm); c) APAM (alginate labeled with FITC - scale 100 μm); d) APACM (chitosan
ly the studied coating was labeled.
Fig. 9. Proﬁle of folic acid release from coated microcapsules at 37 °C in PBS; experimental data (×) and description of LSM (−) for coated microcapsules with A) ﬁrst coating Ɛ-PLL, B)
second coating alginate and C) third coating chitosan.
129P.E. Ramos et al. / Food Research International 90 (2016) 121–132PLL at pH 7 (pH of PBS). Asmentioned above (Section 3.1), at this pH the
interaction between these materials is mainly due to the high afﬁnity
of the charges between the molecules (alginate – negative charge; Ɛ-
PLL – positive charge). Increasing the number of coatings on the coated
microcapsule leads to a decrease of the Fick diffusion contribution andto the appearance of three relaxation steps. In fact, Fig. 10 shows that
the anomalous transport considering two main relaxations (i = 2)
was unable to predict the experimentally observed behavior and,
hence, the physical mechanism of the transport phenomena involved
for the coated microcapsule with the second and third coating was
Table 1
Results of LSM ﬁtting to experimental data of folic acid release from coated microcapsules. Quality of the regression based on RMSE and R2 evaluation. Estimates' precision is evaluated
using the SHW% (in parenthesis).
Layer; D (m2·min−1) MF KF MR1 KR1 MR2 KR2 MR3 KR3 RMS;
R2
APM; 3.73 × 10−13 0.8135
(17.95%)
0.0003
(29.76%)
0.3274
(1.74%)
0.0003
(33.39%)
0.2925
(19.78%)
0.031
(37.90%)
– – 0.1473; 0.9739
APAM; 1.256 × 10−13 0.7645
(20.12%)
0.0001
(30.42%)
0.2259
(37.21%)
0.0001
(18.12%)
0.0509
(27.23%)
0.029
(24.32%)
0.2326
(30.25%)
0.0002
(50.44%)
0.3792; 0.9437
APACM; 1.256 × 10−13 0.7576
(30.27%)
0.0001
(70.2%)
0.2169
(35.4%)
0.0001
(27.28%)
0.2170
(30.12%)
0.0002
(50.52%)
0.1169
(27.32%)
0.0002
(76.98%)
0.6473; 0.9093
D - diffusion coefﬁcient;MF - Fick diffusion contribution;MR - relaxation processes contribution; KF - Fickian rate constant; KR - relaxation rate constant.
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more unstable, whichmeans that the electrostatic interactions between
alginate CR 8223|Ɛ-PLL|alginate LFR5/60 and alginate CR 8223|Ɛ-PLL|
alginate LFR5/60|chitosan are weaker. This leads to the loosening of
coated microcapsule’ structure and promotes the release of folic acid
due to polymer relaxation at different times. Also the relaxation rate
constant (kR) decreased with the number of coatings, supporting this
hypothesis. The rate at which folic acid molecules pass though the coat-
ed microcapsule layers decreases with the increase of the number of
layers in the structure. Fickian rate constant (kF) also decreased withFig. 10. Fitting of Eq. (5) to the experimental data of controlled release of folic acid from coated
model-generated values for i= 2 (−) and i= 3 (−)). Inset shows the detail of the model ﬁttthe number of coatings, reﬂecting the decrease of predominance of
Fickian behavior.
The diffusion coefﬁcient (D) was estimated based on Eq. (4) and it is
possible to observe that this parameter was inﬂuenced by the composi-
tion of the coatings on the coatedmicrocapsule. The application of a sec-
ond coating decreasesD from 3.73× 10−13 to 1.256 × 10−13m2·min−1
and this last value remained constant for the third coating. These results
suggest that the application of the second coating led to a slow, limiting
step of the release of folic acid. This fact can also be explained by the
utilization of two different alginates: the alginate used for themicrocapsules with: A) second coating and B) third coating (experimental results (x) and
ing to the initial experimental data.
131P.E. Ramos et al. / Food Research International 90 (2016) 121–132microcapsule production is more permeable, with a higher swelling ca-
pacity, while the one used as the second coating is more stable, with
moreG residues (more connection points leading to a stronger adhesion
to the adjacent layers), being these characteristics the main differences
of these two alginates (Draget & Taylor, 2011). Similar results in the re-
lease of folic acid from alginate-based capsules can be found in other
works (Madziva, Kailasapathy, & Phillips, 2005; Pérez-Masiá et al.,
2015).
4. Conclusions
This work showed that it is possible to build coated microcapsules
with three coatings (Ɛ-PLL, alginate and chitosan) with a good stability
at different pH values. This allowed us to foresee that this coatedmicro-
capsulemay have a good performance in probiotic protection under GIT
conditions. The coated microcapsule has an average diameter smaller
than 100 μm, thus being not detected in themouth. Results also showed
that its porosity will increase at neutral pH, allowing an increased ex-
change of nutrients and products e.g. between encapsulated cells and
the intestinal medium, although further tests need to be done to show
this. According to the folic acid release experiments it was proved that
this coated microcapsule is permeable to folic acid, even when three
coatings are applied on it, although it was also shown that the increase
of the number of coatings decreases the folic acid diffusivity through
capsules.
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